Award notice, total small business set-aside, first published as combined synopsis and solicitation
Food and Drug Administration (FDA) Office of Clinical Pharmacology (OCP) – Multi-phase/Multi- site Clinical Studies and Laboratory Support Indefinite Delivery-Indefinite Quantity (IDIQ) Type Contract
75F40124R00064
Food and Drug Administration, FDA Office of Acq Grant SVCS. Research and Development in Biotechnology (except Nanobiotechnology).
Awarded
Tranquil Clinical and Research Consulting Services LLC
$50,000,000.00 on the award notice, September 15, 2025, contract 75F40125D00003
Description
As published on SAM.gov.
This is a commercial services Food and Drug Administration (FDA) open market single-award Indefinite Delivery-Indefinite Quantity (IDIQ) type contract set aside 100% for small business. The scope of activities FDA may require of the contractor shall include the capability to conduct multiple Phase I clinical trials within a year and at times in parallel, and the provision of a full range of services to support the clinical trials and reporting of the results. The Authorized Task Order (TO) type under this IDIQ contract is Firm-Fixed-Price (FFP).
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- UEI
- FWWJT8QCEDY4
- CAGE
- 9Z4C3
- Vendor location
- Webster, TX
- Contract
- 75F40125D00003
- Obligated
- $2,500.00, potential $50,000,000
- Actions
- 2 between September 15, 2025 and October 20, 2025
- Competition
- Full and Open Competition After Exclusion of Sources, 3 offers received
- Set-aside reported
- Small Business Set Aside - Total
- Described as
- FFP - Single Award IDIQ - Cder - Office of Clinical Pharmacology Clinical Studies and Laboratory Support
- Match
- award number 75F40125D00003 equals the contract number; same awarding office 75F401 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 18, 2024
Combined synopsis and solicitation, originally sources sought
Due September 2, 2024 at 3:00 PM EDT. SAM.gov, notice bc5a92457170469197e4dd89369a8bfd
August 15, 2024
Combined synopsis and solicitation
Due September 2, 2024 at 3:00 PM EDT. SAM.gov, notice 7241338dfc21472a8dc4cdf40e091aa7
September 16, 2025
Award notice, originally combined synopsis and solicitation
Awarded to TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC Webster for $50,000,000. SAM.gov, notice b5f18d924b64480295b9816059860a6e
Points of contact
- Craig Wrightcraig.wright@fda.hhs.gov240-402-3996
- Ian WeissIan.Weiss@fda.hhs.gov3017965728
Also open from this buyer
- Human Hindbrain Organoid Functional Assay Services.Combined synopsis and solicitationNAICS 541714RFQ_CDR-2026-135968Closes todaySep 17
- Animal BloodCombined synopsis and solicitationSmall businessNAICS 325414Silver Spring, MDCDRH2026134634Closes tomorrowSep 18
- Rapid Nicotine Pouch Data Analysis ServicesCombined synopsis and solicitationNAICS 541618Silver Spring, MD75F40126Q00407Closes tomorrowSep 18
- Vanquish Neo System and Ion Chromatography systemSolicitationNAICS 33451675F40126Q000430Closes in 4 daysSep 21
- Fourier Transform Infrared Spectrophotometer (FTIR)Combined synopsis and solicitationNAICS 334516San Juan, PR75F40126Q00406Closes in 5 daysSep 22